Skip to content
10-Q

Quarterly Report

KINNATE BIOPHARMA INC.

0001140361-23-038597

← back to feed
Filed
Aug 8, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 4, 2023 47.09M sh
Shares Diluted Q2 2023 · Jun 30, 2023 46.66M sh
Shares Diluted Q2 2023 · Jun 30, 2023 46.04M sh
Shares Diluted Q2 2023 · Jun 30, 2022 44M sh
Shares Diluted Q2 2023 · Jun 30, 2022 43.94M sh
Capex Q2 2023 · Jun 30, 2023 $0
Capex Q2 2023 · Jun 30, 2022 $2.57M
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$57.14M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$44.63M
Short Term Investments Q2 2023 · Jun 30, 2023 $150.2M
Short Term Investments Q2 2023 · Dec 31, 2022 $172.21M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $34.51M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $29.26M
Stockholders Equity Q2 2023 · Jun 30, 2023 $197.62M
Stockholders Equity Q2 2023 · Mar 31, 2023 $222.76M
Stockholders Equity Q2 2023 · Dec 31, 2022 $223.47M
Stockholders Equity Q2 2023 · Jun 30, 2022 $273.73M
Stockholders Equity Q2 2023 · Mar 31, 2022 $295.82M
Stockholders Equity Q2 2023 · Dec 31, 2021 $319.48M
Current Liabilities Q2 2023 · Jun 30, 2023 $15.77M
Current Liabilities Q2 2023 · Dec 31, 2022 $17.17M
Total Liabilities Q2 2023 · Jun 30, 2023 $18.52M
Total Liabilities Q2 2023 · Dec 31, 2022 $20.36M
Current Assets Q2 2023 · Jun 30, 2023 $188.6M
Current Assets Q2 2023 · Dec 31, 2022 $230.84M
Total Assets Q2 2023 · Jun 30, 2023 $216.14M
Total Assets Q2 2023 · Dec 31, 2022 $278.83M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.68
Eps Diluted Q2 2023 · Jun 30, 2023 −$1.41
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.62
Eps Diluted Q2 2023 · Jun 30, 2022 −$1.23
Eps Basic Q2 2023 · Jun 30, 2023 −$0.68
Eps Basic Q2 2023 · Jun 30, 2023 −$1.41
Eps Basic Q2 2023 · Jun 30, 2022 −$0.62
Eps Basic Q2 2023 · Jun 30, 2022 −$1.23
Sga Expense Q2 2023 · Jun 30, 2023 $7.81M
Sga Expense Q2 2023 · Jun 30, 2023 $15.9M
Sga Expense Q2 2023 · Jun 30, 2022 $7.64M
Sga Expense Q2 2023 · Jun 30, 2022 $15.05M
Rd Expense Q2 2023 · Jun 30, 2023 $26.33M
Rd Expense Q2 2023 · Jun 30, 2023 $52.89M
Rd Expense Q2 2023 · Jun 30, 2022 $19.77M
Rd Expense Q2 2023 · Jun 30, 2022 $39.41M
Operating Income Q2 2023 · Jun 30, 2023 −$34.14M
Operating Income Q2 2023 · Jun 30, 2023 −$68.79M
Operating Income Q2 2023 · Jun 30, 2022 −$27.41M
Operating Income Q2 2023 · Jun 30, 2022 −$54.47M